2 METHODS
We registered our protocol on PROSPERO (CRD42022366513) and the study
adheres to the Preferred Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) guidelines for NMAs (Supplementary Table
1).13
2.1 Search strategy and eligibility criteria
We comprehensively searched PubMed (up to April 24, 2022), Embase (using
the OVID platform: from 1974 to January 2022), MEDLINE (OVID MEDLINE
(R):from 1946 to Present), and the Cochrane Library (CENTRAL) from
inception to the first quarter of
2022. We searched ClinicalTrials.gov and the reference lists of key
reviews and meta-analyses to supplement the identified citations.
Searches included terms relating to
triamcinolone acetonide, macular
edema, and randomized controlled trials (Supplementary Table 2).